Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.320
+0.080 (3.57%)
At close: May 12, 2025, 4:00 PM
2.320
0.00 (0.00%)
After-hours: May 12, 2025, 7:12 PM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $66.96 million as of May 12, 2025. Its market cap has decreased by -47.52% in one year.
Market Cap
66.96M
Enterprise Value
-19.89M
1-Year Change
-47.52%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $66.96M, an increase of 620.00%. That is a compound annual growth rate of 24.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 64.70M | -21.19% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |